PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsXeris Pharmaceuticals
Xeris Pharmaceuticals(XERS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
KeveyisDichlorphenamide1982-01-01
Glaucoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glucagon
healthy volunteers/patients
,
hypoglycemia
,
tobacco use disorder
,
smoking cessation
,
psoriatic arthritis
,
psoriasis
,
arthritis
,
non-alcoholic fatty liver disease
,
pouchitis
,
parkinson disease
,
nutrition disorders
,
prediabetic state
,
glucose intolerance
,
bulimia
,
feeding and eating disorders
,
binge-eating disorder
,
polycystic ovary syndrome
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
diabetes mellitus
,
type 2 diabetes mellitus
,
obesity
,
overweight
,
type 1 diabetes mellitus
,
weight loss
,
body weight
,
cardiovascular diseases
,
fatty liver
,
metabolic syndrome
,
diastolic heart failure
,
insulin resistance
,
hypertension
,
diabetic nephropathies
,
chronic kidney failure
,
renal insufficiency
,
gestational diabetes
,
prader-willi syndrome
,
syndrome
,
essential hypertension
,
systolic murmurs
,
isolated systolic hypertension
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
abdominal obesity
,
lipid metabolism disorders
,
knee osteoarthritis
,
osteoarthritis
,
myocardial reperfusion
,
kidney diseases
,
diabetes complications
,
osteoporosis
,
body weight changes
,
appetitive behavior
,
motor activity
,
carcinoma
,
thyroid neoplasms
,
neuroendocrine carcinoma
,
papillary thyroid cancer
,
thyroid diseases
,
multiple endocrine neoplasia type 1
,
heart failure
,
hyperglycemia
,
inflammation
Bevifimod
retinal diseases
,
macular degeneration
,
wet macular degeneration
,
retinal degeneration
,
eye diseases
,
retinal neovascularization
Insulin
rheumatoid arthritis
,
arthritis
,
neoplasms
,
hyperkalemia
,
hypertension
,
type 1 diabetes mellitus
,
obesity
,
hypoglycemia
,
diabetic retinopathy
,
heart failure
,
polycystic ovary syndrome
,
type 2 diabetes mellitus
,
diabetes mellitus
,
insulin resistance
,
hyperglycemia
,
cardiovascular diseases
,
hypersensitivity
,
breast neoplasms
,
urinary bladder neoplasms
,
pancreatitis
,
healthy volunteers/patients
,
congenital abnormalities
,
premature birth
,
gestational diabetes
,
pregnancy in diabetics
,
pancreatic neoplasms
Viaject
rheumatoid arthritis
,
arthritis
,
neoplasms
,
hyperkalemia
,
hypertension
,
type 1 diabetes mellitus
,
obesity
,
hypoglycemia
,
diabetic retinopathy
,
heart failure
,
polycystic ovary syndrome
,
type 2 diabetes mellitus
,
diabetes mellitus
,
insulin resistance
,
hyperglycemia
,
cardiovascular diseases
,
hypersensitivity
,
breast neoplasms
,
urinary bladder neoplasms
,
pancreatitis
,
healthy volunteers/patients
,
congenital abnormalities
,
premature birth
,
gestational diabetes
,
pregnancy in diabetics
,
pancreatic neoplasms
Pram9
type 1 diabetes mellitus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use